Nutriangels launched K2 + featuring MenaQ7 in Q2 2017 and has already been well received, said NattoPharma in a press release. Because of NattoPharma’s extensive clinical substantiation and awarded patents, K2 + is positioned to support both bone and cardiovascular health.
“Brazil is a burgeoning market where NattoPharma already enjoys an established presence. Nutriangels is one of the new pioneering supplement brands serving Brazil and we are thrilled to see this new customer expand our MenaQ7 offering with consumer-targeted, science-based products,” said Eric Anderson, senior vice president of global sales and marketing with NattoPharma.
“This milestone marks a welcome increase in awareness of the importance of Vitamin K2 for human health, and the global recognition that MenaQ7 is the clinically validated branded Vitamin K2 as MK-7 of choice,” he added.